| MeSH term | MeSH ID | Detail |
|---|---|---|
| Thrombocytopenia | D013921 | 15 associated lipids |
| Thrombocythemia, Essential | D013920 | 9 associated lipids |
| Thromboangiitis Obliterans | D013919 | 4 associated lipids |
| Thrombasthenia | D013915 | 4 associated lipids |
| Takayasu Arteritis | D013625 | 3 associated lipids |
| Tachycardia, Supraventricular | D013617 | 3 associated lipids |
| Tachycardia, Paroxysmal | D013614 | 2 associated lipids |
| Tachycardia | D013610 | 7 associated lipids |
| Subarachnoid Hemorrhage | D013345 | 17 associated lipids |
| Strongyle Infections, Equine | D013319 | 1 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Böhm E et al. | 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. | 2004 | J. Biol. Chem. | pmid:14668348 |
| Persico N et al. | Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients. | 2004 | Gynecol. Endocrinol. | pmid:15726916 |
| He J et al. | Treatment of unstable angina pectoris with modified nuan gan jian--a report of 33 cases. | 2004 | J Tradit Chin Med | pmid:15688691 |
| Arruzazabala ML et al. | Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers. | 2004 | Int J Clin Pharmacol Res | pmid:15689052 |
| Kudolo GB et al. | The ingestion of Ginkgo biloba extract (EGb 761) inhibits arachidonic acid-mediated platelet aggregation and thromboxane B2 production in healthy volunteers. | 2004 | J Herb Pharmacother | pmid:15927922 |
| Lam AN et al. | Effect of red clover isoflavones on cox-2 activity in murine and human monocyte/macrophage cells. | 2004 | Nutr Cancer | pmid:15456640 |
| Xu L et al. | [Effects of effective component from "qing kai ling" on endothelial cell of microvessel in MCAO rats]. | 2004 | Zhong Yao Cai | pmid:15376390 |
| Perneby C et al. | Prothrombotic responses to exercise are little influenced by clopidogrel treatment. | 2004 | Thromb. Res. | pmid:15381386 |
| Hennekens CH et al. | Terms and conditions: semantic complexity and aspirin resistance. | 2004 | Circulation | pmid:15381661 |
| Zhao GR et al. | [Clinical study on relationship between sluggishness of lung-defensive qi and levels of vasoactive intestinal polypeptide and thromboxane B2]. | 2004 | Zhong Xi Yi Jie He Xue Bao | pmid:15383251 |
| Fiorucci S et al. | Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. | 2004 | J. Am. Coll. Cardiol. | pmid:15358033 |
| Ming HX et al. | [Influence of single leaf Asarum himalaicum on renal function of rabbits]. | 2004 | Zhong Xi Yi Jie He Xue Bao | pmid:15339444 |
| Dey A et al. | Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. | 2004 | Obes. Res. | pmid:15340111 |
| Sheu JR et al. | Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. | 2004 | Br. J. Pharmacol. | pmid:15289295 |
| Toth B et al. | Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. | 2004 | J. Appl. Physiol. | pmid:15298985 |
| Devi MM and Das UN | Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro. | 2004 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:15380818 |
| Korkushko OV et al. | [Some mechanisms of the development of endothelial disfunction in aging]. | 2004 | Fiziol Zh | pmid:15174205 |
| Kawano T et al. | Acetaldehyde induces histamine release from human airway mast cells to cause bronchoconstriction. | 2004 | Int. Arch. Allergy Immunol. | pmid:15178893 |
| Ishitsuka Y et al. | Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs. | 2004 | J. Pharm. Pharmacol. | pmid:15099446 |
| Dinev D and Andonova M | The effect of general anesthesia and abdominal surgery upon plasma thromboxane B concentrations in horses. | 2004 | Vet Anaesth Analg | pmid:15053753 |
| Menzies-Gow NJ et al. | Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. | 2004 | Equine Vet. J. | pmid:15147137 |
| Ghuysen A et al. | Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism. | 2004 | J. Pharmacol. Exp. Ther. | pmid:15121765 |
| Caprani A et al. | Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure. | 2004 | Bioelectromagnetics | pmid:15114641 |
| Di Minno G and Violi F | Aspirin resistance and diabetic angiopathy: back to the future. | 2004 | Thromb. Res. | pmid:15115664 |
| Torsney E et al. | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. | 2004 | Circ. Res. | pmid:15117816 |
| Wang YY et al. | Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism. | 2004 | Acta Pharmacol. Sin. | pmid:15066215 |
| Harizi H et al. | Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. | 2004 | Cell. Immunol. | pmid:15219461 |
| Park HS et al. | Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. | 2004 | J. Nutr. Biochem. | pmid:15068816 |
| Zhang C et al. | Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats. | 2004 | J. Cardiovasc. Pharmacol. | pmid:15071353 |
| Bruno A et al. | Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. | 2004 | Stroke | pmid:14963281 |
| Kwak SH et al. | Effects of propofol on endotoxin-induced acute lung injury in rabbit. | 2004 | J. Korean Med. Sci. | pmid:14966342 |
| de La Puerta Vázquez R et al. | Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. | 2004 | Metab. Clin. Exp. | pmid:14681843 |
| Minuz P et al. | Determinants of platelet activation in human essential hypertension. | 2004 | Hypertension | pmid:14656953 |
| Capone ML et al. | Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Circulation | pmid:15037526 |
| Liu P et al. | [Effects of the extracts from decoction for resuscitation and its component herbs on PGI2, TXA2 and NO release from rat vascular endothelial cells under hypoxia in vitro]. | 2004 | Zhongguo Zhong Yao Za Zhi | pmid:15631091 |
| Yang JP et al. | [Changes of the platelet function and serum anticardiolipin antibody in patients with pulmonary thromboembolism]. | 2004 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:15634381 |
| Wang MS et al. | [The effects of lupus anticoagulant on pulmonary thromboembolism]. | 2004 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:15634384 |
| Franz KB | A functional biological marker is needed for diagnosing magnesium deficiency. | 2004 | J Am Coll Nutr | pmid:15637224 |
| Ganafa AA et al. | Amlodipine attenuates oxidative stress-induced hypertension. | 2004 | Am. J. Hypertens. | pmid:15363814 |
| Cardoni RL and Antúnez MI | Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. | 2004 | Mediators Inflamm. | pmid:15545053 |
| Wu JX et al. | Changes in somatostatin receptor expression of the pancreas and effectiveness of octreotide in rats with acute necrotizing pancreatitis. | 2004 | Chin J Dig Dis | pmid:15612670 |
| Berrougui H et al. | Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. | 2004 | Br. J. Nutr. | pmid:15613254 |
| Fan JG et al. | [Dynamic changes of plasma levels of prostacycline and thromboxane A2 and their correlation with the severity of hepatic injury in rats with nonalcoholic fatty liver disease]. | 2004 | Zhonghua Gan Zang Bing Za Zhi | pmid:15623379 |
| DÃaz AM et al. | Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity. | 2004 | Life Sci. | pmid:15010262 |
| Rotondo S et al. | Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. | 2004 | Eur. J. Pharmacol. | pmid:15044038 |
| Guay J et al. | Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. | 2004 | J. Biol. Chem. | pmid:15044444 |
| Véricel E et al. | Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. | 2004 | Diabetes | pmid:15047620 |
| Yugar-Toledo JC et al. | Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. | 2004 | Chest | pmid:15006938 |
| Akbiyik F et al. | Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. | 2004 | Blood | pmid:15130939 |
| Tanigawa T et al. | Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:12958020 |